Thanks for that information. It adds to the picture developing.
Looks like 60% of the trial cost is being borne by the Rett foundation. Dadgum, that means the money in the bank at AVXL is going to last a lot longer than has been expected by the more conservative views.
If that can be done for other trials, AVXL won't be tapping that funding mechanism as hard as might be expected.